2014 Q2 Form 10-Q Financial Statement

#000114420414049079 Filed on August 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q4 2013 Q2
Revenue $630.1K $590.0K $553.8K
YoY Change 13.78% 13.46% 33.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $180.0K $290.0K $200.0K
YoY Change -10.0% -9.38% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $180.0K $280.0K $210.0K
YoY Change -14.29% -12.5% 5.0%
Operating Profit $331.1K $247.0K
YoY Change 34.02% 56.46%
Interest Expense -$120.0K -$120.0K -$100.0K
YoY Change 20.0% 33.33% 66.67%
% of Operating Profit -36.24% -40.48%
Other Income/Expense, Net $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Pretax Income $338.0K $150.0K $253.9K
YoY Change 33.1% 36.36% 54.1%
Income Tax -$83.00K $90.00K $96.00K
% Of Pretax Income -24.56% 60.0% 37.81%
Net Earnings $421.0K $60.00K $157.9K
YoY Change 166.56% 100.0% 97.22%
Net Earnings / Revenue 66.81% 10.17% 28.52%
Basic Earnings Per Share $0.10 $0.04
Diluted Earnings Per Share $0.10 $13.99K $0.04
COMMON SHARES
Basic Shares Outstanding 4.284M shares 4.275M shares
Diluted Shares Outstanding 4.323M shares 4.289M shares

Balance Sheet

Concept 2014 Q2 2013 Q4 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $140.0K $1.020M $1.090M
YoY Change -87.16% 325.0% 541.18%
Cash & Equivalents $135.5K $1.021M $1.094M
Short-Term Investments
Other Short-Term Assets $50.00K $18.54K $51.11K
YoY Change -2.16% -1.92% 2.21%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $11.80M $11.91M $12.10M
YoY Change -2.45% 4.07% 76.07%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $210.0K $210.0K $250.0K
YoY Change -16.0% -16.0% 0.0%
Other Assets $204.4K $0.00 $20.00K
YoY Change 922.15% -100.0% -71.43%
Total Long-Term Assets $5.930M $4.215M $3.665M
YoY Change 61.82% 45.53% -24.44%
TOTAL ASSETS
Total Short-Term Assets $11.80M $11.91M $12.10M
Total Long-Term Assets $5.930M $4.215M $3.665M
Total Assets $17.73M $16.12M $15.76M
YoY Change 12.5% 12.45% 34.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.00K $60.00K $20.00K
YoY Change 150.0% -14.29% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.320M $1.319M $1.159M
YoY Change 13.85% -5.72% -56.08%
Long-Term Debt Due $6.600M $5.350M $5.500M
YoY Change 20.0% 33.75%
Total Short-Term Liabilities $8.274M $7.232M $7.038M
YoY Change 17.56% 23.4% 140.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.274M $7.232M $7.038M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $8.270M $7.230M $7.040M
YoY Change 17.47% 23.38% 105.25%
SHAREHOLDERS EQUITY
Retained Earnings -$487.7K -$654.3K
YoY Change -48.26%
Common Stock $9.750M $9.723M
YoY Change 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $369.3K $346.0K
YoY Change 36.8%
Treasury Stock Shares 177.0K shares 177.0K shares 163.0K shares
Shareholders Equity $9.460M $8.893M $8.722M
YoY Change
Total Liabilities & Shareholders Equity $17.73M $16.12M $15.76M
YoY Change 12.5% 12.45% 34.47%

Cashflow Statement

Concept 2014 Q2 2013 Q4 2013 Q2
OPERATING ACTIVITIES
Net Income $421.0K $60.00K $157.9K
YoY Change 166.56% 100.0% 97.22%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities $400.0K $240.0K $270.0K
YoY Change 48.15% 9.09% 440.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.350M $710.0K -$1.650M
YoY Change -18.18% -175.53% 46.02%
Cash From Investing Activities -$1.350M $710.0K -$1.650M
YoY Change -18.18% -175.53% 46.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.080M 10.00K 2.230M
YoY Change -51.57% -98.67% 84.3%
NET CHANGE
Cash From Operating Activities 400.0K 240.0K 270.0K
Cash From Investing Activities -1.350M 710.0K -1.650M
Cash From Financing Activities 1.080M 10.00K 2.230M
Net Change In Cash 130.0K 960.0K 850.0K
YoY Change -84.71% 3100.0% 553.85%
FREE CASH FLOW
Cash From Operating Activities $400.0K $240.0K $270.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135495 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1021023 USD
CY2013Q4 loan Short Term Loans Receivable
ShortTermLoansReceivable
10697950 USD
CY2014Q2 loan Additional Construction Loan For Borrowers Subject To Conditions
AdditionalConstructionLoanForBorrowersSubjectToConditions
1555500 USD
CY2014Q2 loan Jointly Funded Loans Total
JointlyFundedLoansTotal
2275000 USD
CY2014Q2 loan Jointly Funded Loans
JointlyFundedLoans
1450000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-83000 USD
CY2014Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6887 USD
CY2013Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
14183000 USD
CY2014Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
16920967 USD
CY2014Q2 loan Short Term Loans Receivable
ShortTermLoansReceivable
11415967 USD
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
171483 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18540 USD
CY2014Q2 loan Exercise Price Of Remaining Property
ExercisePriceOfRemainingProperty
146821 USD
CY2014Q2 loan Monthly Option Fee For Property After Partial Exercise Of Option
MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption
2296 USD
loan Property Selling Price
PropertySellingPrice
415000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
11908996 USD
CY2013Q4 loan Investment In Real Estate
InvestmentInRealEstate
146821 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
204429 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2014Q2 us-gaap Security Deposit
SecurityDeposit
6637 USD
CY2013Q4 us-gaap Security Deposit
SecurityDeposit
6637 USD
CY2014Q2 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49416 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
57066 USD
CY2014Q2 loan Deferred Origination Fees
DeferredOriginationFees
174889 USD
CY2013Q4 loan Deferred Origination Fees
DeferredOriginationFees
132017 USD
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
130224 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
373219 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8273994 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7231767 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
675000 USD
CY2011Q1 loan Option Sold
OptionSold
3900 USD
CY2011Q1 loan Option Monthly Fee
OptionMonthlyFee
10530 USD
loan Fees Generated From Seller Buy Back Options
FeesGeneratedFromSellerBuyBackOptions
13774 USD
loan Fees Generated From Seller Buy Back Options
FeesGeneratedFromSellerBuyBackOptions
13774 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4278868 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4270074 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4274562 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4283805 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11120 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
33668 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14572 shares
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
39221 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4289988 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
270428 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
47779 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
285000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
49000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
147000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
89000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
87000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.97
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.75
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.26
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.27
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y6M22D
CY2014Q2 loan Share Based Compensation Arrangement By Share Based Payment Award Vested And Non Vested Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndNonVestedOptionsOutstandingIntrinsicValue
64519 USD
CY2014Q2 loan Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue
63321 USD
loan Share Based Compensation Expense
ShareBasedCompensationExpense
8518 USD
loan Share Based Compensation Expense
ShareBasedCompensationExpense
6832 USD
CY2013Q2 loan Share Based Compensation Expense
ShareBasedCompensationExpense
5102 USD
CY2014Q2 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3416 USD
loan Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors
The options may vest over a period not to exceed ten years. Stock options under our stock option plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under our stock option plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office.
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0261 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0107 pure
CY2011 loan Operating Lease Term Of Lease
OperatingLeaseTermOfLease
five years and two months
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
55230 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4482190 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4433190 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4305190 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4256190 shares
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
loan Interest Income From Loans
InterestIncomeFromLoans
892301 USD
loan Interest Income From Loans
InterestIncomeFromLoans
1025436 USD
CY2013Q2 loan Interest Income From Loans
InterestIncomeFromLoans
447522 USD
CY2014Q2 loan Interest Income From Loans
InterestIncomeFromLoans
518065 USD
loan Origination Fees
OriginationFees
195855 USD
loan Origination Fees
OriginationFees
213556 USD
CY2013Q2 loan Origination Fees
OriginationFees
106273 USD
CY2014Q2 loan Origination Fees
OriginationFees
112017 USD
us-gaap Revenues
Revenues
1088156 USD
us-gaap Revenues
Revenues
1238992 USD
CY2013Q2 us-gaap Revenues
Revenues
553795 USD
CY2014Q2 us-gaap Revenues
Revenues
630082 USD
loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
204206 USD
loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
239329 USD
CY2013Q2 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
101560 USD
CY2014Q2 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
122906 USD
loan Referral Fees
ReferralFees
929 USD
loan Referral Fees
ReferralFees
384 USD
CY2013Q2 loan Referral Fees
ReferralFees
334 USD
CY2014Q2 loan Referral Fees
ReferralFees
275 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
377725 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
351808 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
204857 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
175812 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
582860 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
591521 USD
CY2013Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
306751 USD
CY2014Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
298993 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
505296 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
647471 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
247044 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
331089 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13774 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13774 USD
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6887 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
519070 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
661245 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
253931 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
337976 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
188000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
96000 USD
us-gaap Net Income Loss
NetIncomeLoss
331070 USD
us-gaap Net Income Loss
NetIncomeLoss
629245 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
157931 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
420976 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
22540 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
23538 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8518 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6832 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
76 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
28762 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
32202 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
31888 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-50638 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7651 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
-54523 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
-42873 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-86120 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-242995 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
248613 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
367654 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
8430500 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
9764000 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
7871866 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
7537983 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-558634 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2226017 USD
loan Proceeds From Loans And Line Of Credit
ProceedsFromLoansAndLineOfCredit
1260000 USD
loan Proceeds From Loans And Line Of Credit
ProceedsFromLoansAndLineOfCredit
1250000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
76053 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
204429 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
42786 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
127966 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1163701 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
972835 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
853680 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-885528 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240693 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1094373 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
274120 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
274995 USD
us-gaap Interest Paid
InterestPaid
180667 USD
us-gaap Interest Paid
InterestPaid
239329 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN BRIDGE CAPITAL, INC
dei Entity Central Index Key
EntityCentralIndexKey
0001080340
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
LOAN
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6059576 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.78
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30

Files In Submission

Name View Source Status
0001144204-14-049079-index-headers.html Edgar Link pending
0001144204-14-049079-index.html Edgar Link pending
0001144204-14-049079.txt Edgar Link pending
0001144204-14-049079-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
loan-20140630.xml Edgar Link completed
loan-20140630.xsd Edgar Link pending
loan-20140630_cal.xml Edgar Link unprocessable
loan-20140630_def.xml Edgar Link unprocessable
loan-20140630_lab.xml Edgar Link unprocessable
loan-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v385721_10q.htm Edgar Link pending
v385721_ex3-1.htm Edgar Link pending
v385721_ex3-2.htm Edgar Link pending
v385721_ex31-1.htm Edgar Link pending
v385721_ex31-2.htm Edgar Link pending
v385721_ex32-1.htm Edgar Link pending
v385721_ex32-2.htm Edgar Link pending